clinical trial · NCT03115086
The REPLACE Registry for Cholbam® (Cholic Acid)
Bile Acid Synthesis DisordersCholbam
brief summary
This is a prospective, observational, non-interventional patient registry study designed to document product safety and effectiveness outcomes for 10 years in patients treated with Cholbam, including those who have been using Cholbam for at least 30 days (existing users) and those who are first-time initiators of Cholbam.
started
Jul 10, 2017
primary completion
Jul 1, 2038
completion
Jul 1, 2039
last updated
Oct 2, 2023
detailed description
No experimental intervention is involved. Patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician.
official title
A Prospective, Observational, Non-Interventional, Post-Marketing, Patient Registry to Collect Data on Routine Clinical Care in Patients Treated With Cholbam® (Cholic Acid)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol